Àν¶¸° Àü´Þ ±â±â ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç°º°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)
Insulin Delivery Devices Market Size, Share & Trends Analysis Report By Product (Reusable Insulin Pens, Disposable Insulin Pens), By End Use (Hospitals & Clinics, Homecare), By Region, And Segment Forecasts, 2024 - 2030
»óǰÄÚµå : 1529625
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,311,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,708,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,502,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Àν¶¸° Àü´Þ ±â±â ½ÃÀå ¼ºÀå ¹× µ¿Çâ:

Àν¶¸° Àü´Þ ±â±â ¼¼°è ½ÃÀå ±Ô¸ð´Â 2030³â 280¾ï 6,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 7.89% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÁÖ·Î ÀþÀº ÃþÀÇ ºñ¸¸, ÁÂ½Ä »ýȰ½À°ü, °Ç°­¿¡ ÇØ·Î¿î ½Ä½À°üÀÌ ´ç´¢º´ ¹ß»ýÀÇ ÁÖ¿ä ¿øÀÎÀ¸·Î ²ÅÈü´Ï´Ù. ¶ÇÇÑ ´ç´¢º´ ³ë³âÃþ Àα¸ÀÇ Áõ°¡µµ ÀÌ ºÐ¾ßÀÇ ¼ºÀåÀ» µÞ¹ÞħÇÏ´Â ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. À¯¿£ °æÁ¦»çȸ±¹¿¡ µû¸£¸é 2015³â ¾à 9¾ï 1,000¸¸ ¸íÀÌ 60¼¼ ÀÌ»óÀ̸ç, ÀÌ ¼ýÀÚ´Â 2030³â±îÁö 14¾ï ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌó·³ ³ëÀÎ Àα¸ÀÇ Áõ°¡´Â Àν¶¸° Àü´Þ ±â±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±â¼ú Çõ½Å°ú ¹ßÀüÀº ÀÌ ºÐ¾ß¿¡¼­ Áö¼ÓÀûÀÎ Ãß¼¼ÀÔ´Ï´Ù. ÷´Ü Àν¶¸° Àü´Þ ±â±â¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä´Â ÃÖ±Ù Ãâ½ÃµÈ Çõ½ÅÀûÀÎ ÆæÇü ÀåÄ¡¿Í ÈÞ´ë¿ë ÆßÇÁÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¶ÇÇÑ ¹Ì±¹°ú µ¶Àϰú °°Àº ¼±Áø±¹À» Áß½ÉÀ¸·Î ÀÌ·¯ÇÑ ÀåÄ¡¿¡ ´ëÇÑ À¯¸®ÇÑ »óȯ Á¤Ã¥Àº Á¶»ç ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª Àν¶¸° Àü´Þ ±â±âÀÇ ½ÂÀÎÀ» ±ÔÁ¦ÇÏ´Â ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç°ú ´ç´¢º´ °ü¸®¿¡¼­ Àν¶¸° À¯»çüÀÇ ³ôÀº ºñ¿ëÀº ÀÌ »ê¾÷ÀÇ ¼ºÀåÀ» ¾ïÁ¦ÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.

ÀÌ ½ÃÀåÀÇ Àú¸íÇÑ °æÀï»çµéÀº Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ È®ÀåÇϰí Á¦Á¶ ¿ª·®À» °­È­Çϱâ À§ÇØ Àμö, ÀÚ±Ý Á¶´Þ, Á¦Ç° °³¹ß µî ´Ù¾çÇÑ ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 10¿ù Eli Lilly´Â Cipla¿Í Á¦ÈÞÇÏ¿© Àεµ¿¡¼­ Àν¶¸° Á¦Á¦(Humalog ¹× Trulicity)¸¦ ÆÇ¸ÅÇÒ ¿¹Á¤ÀÔ´Ï´Ù. ¶ÇÇÑ 2021³â 6¿ù¿¡´Â ½ÃÀå ÀÔÁö¸¦ °­È­Çϱâ À§ÇØ ÇÁ·ÎÅä¸Ó Å×Å©³î·¯Áö½º(Protomer Technologies)¸¦ ÀμöÇß½À´Ï´Ù. ¶ÇÇÑ Novo Nordisk´Â Biocorp¿Í Çù·ÂÇÏ¿© ÆæÇü Àν¶¸° ÁÖ»ç±â¿ë ºí·çÅõ½º Áö¿ø ½º¸¶Æ® ¾Öµå¿Â ÀåÄ¡¸¦ °³¹ßÇß½À´Ï´Ù.

Àν¶¸° Àü´Þ ±â±â ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Àν¶¸° Àü´Þ ±â±â ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå Àν¶¸° Àü´Þ ±â±â ½ÃÀå : Á¦Ç° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå Àν¶¸° Àü´Þ ±â±â ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå Àν¶¸° Àü´Þ ±â±â ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®, Á¦Ç°º°, ÃÖÁ¾ ¿ëµµº°

Á¦7Àå °æÀï »óȲ

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Insulin Delivery Devices Market Growth & Trends:

The global insulin delivery devices market size was estimated at USD 28.06 billion in 2030 and is expected to grow at a CAGR of 7.89% from 2024 to 2030. Obesity, sedentary lifestyles, and unhealthy food habits, primarily in the young population, lead to the occurrence of diabetes. In addition, the growing diabetic geriatric population is another factor supporting the growth of this vertical. According to the United Nations, Department of Economic and Social Affairs, around 901 million individuals were aged 60 or over in 2015 and this number is projected to increase to 1.4 billion by 2030. Thus, the enlarging elderly population is expected to boost the demand for insulin delivery devices.

Technological innovations and advancements are an ongoing trend in this vertical. The high demand for advanced insulin delivery devices is supporting the adoption of recently launched innovative pen devices and portable pumps, which is estimated to boost the market growth. Also, favorable reimbursement policies for these devices, mainly in developed countries like the U.S. and Germany, are anticipated to fuel the market growth during the study period. However, stringent regulatory requirements regulating the approval of insulin delivery devices and the high cost of insulin analogs in diabetes care management are major factors restraining the growth of this industry.

The market's prominent competitors are taking different initiatives such as acquisition, funding, and product development to expand their product portfolio and enhance their manufacturing capacity. For instance, in October 2021, Eli Lilly partnered with Cipla, to market its Insulin products (Humalog and Trulicity) in India. Additionally, In June 2021, the company acquired Protomer Technologies, to strengthen its market presence. Further, Novo Nordisk, joined hands with Biocorp to develop a Bluetooth-enabled smart add-on device for their pen insulin injector.

Insulin Delivery Devices Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Insulin Delivery Devices Market Variables, Trends & Scope

Chapter 4. Insulin Delivery Devices Market: Product Estimates & Trend Analysis

Chapter 5. Insulin Delivery Devices Market: End Use Estimates & Trend Analysis

Chapter 6. Insulin Delivery Devices Market: Regional Estimates & Trend Analysis By Product, End Use

Chapter 7. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â